CNS Relapse Incidence and Survival Outcomes in Patients With High-Risk DLBCL Receiving High-Dose Methotrexate CNS Prophylaxis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
American Journal of Hematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Diffuse large B-cell lymphoma at risk of secondary CNS involvement: The inefficacy of intravenous high-dose methotrexate CNS prophylaxis and the importance of baseline cerebrospinal fluid analysis
Am. J. Hematol 2023 May 10;[EPub Ahead of Print], R Bennett, A Ruskova, C Coomarasamy, E Theakston, L Berkahn, S Jackson, M Christophers, S Wong, S IssaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.